Molecular mechanisms of fMLP-induced superoxide generation and degranulation in mouse neutrophils

Advances in Biological Regulation

Volumn 53, Issue 1, 2013, Pages 128-134

  Kanaho, Yasunori ^a   Sato, Takanobu ^a   Hongu, Tsunaki ^a   Funakoshi, Yuji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874012705     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2012.09.001     Document Type: Article

References (58)

1. Alvarez Y.D., Marengo F.D. The immediately releasable vesicle pool: highly coupled secretion in chromaffin and other neuroendocrine cells. J Neurochem 2011, 116:155-163.
2. Azuma Y., Kosaka K., Kashimata M. Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP. Eur J Pharmacol 2007, 568:260-268.
3. Banno Y., Nemoto S., Murakami M., Kimura M., Ueno Y., Ohguchi K., et al. Depolarization-induced differentiation of PC12 cells is mediated by phospholipase D2 through the transcription factor CREB pathway. J Neurochem 2008, 104:1372-1386.
4. Bertram A., Ley K. Protein kinase C isoforms in neutrophil adhesion and activation. Arch Immunol Ther Exp (Warsz) 2011, 59:79-87.
5. Bonser R.W., Thompson N.T., Randall R.W., Garland L.G. Phospholipase D activation is functionally linked to superoxide generation in the human neutrophil. Biochem J 1989, 264:617-620.
6. Cai J., Abramovici H., Gee S.H., Topham M.K. Diacylglycerol kinases as sources of phosphatidic acid. Biochim Biophys Acta 2009, 1791:942-948.
7. Choi W.S., Kim Y.M., Combs C., Frohman M.A., Beaven M.A. Phospholipases D1 and D2 regulate different phases of exocytosis in mast cells. J Immunol 2002, 168:5682-5689.
8. Cockcroft S. Signalling roles of mammalian phospholipase D1 and D2. Cell Mol Life Sci 2001, 58:1674-1687.
9. Colley W.C., Sung T.C., Roll R., Jenco J., Hammond S.M., Altshuller Y., et al. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol 1997, 7:191-201.
10. Colvin R.A., Means T.K., Diefenbach T.J., Moita L.F., Friday R.P., Sever S., et al. Synaptotagmin-mediated vesicle fusion regulates cell migration. Nat Immunol 2010, 11:495-502.
11. de Chaffoy de Courcelles D.C., Roevens P., Van Belle H. R 59 022, a diacylglycerol kinase inhibitor. Its effect on diacylglycerol and thrombin-induced C kinase activation in the intact platelet. J Biol Chem 1985, 260:15762-15770.
12. Du G., Altshuller Y.M., Kim Y., Han J.M., Ryu S.H., Morris A.J., et al. Dual requirement for rho and protein kinase C in direct activation of phospholipase D1 through G protein-coupled receptor signaling. Mol Biol Cell 2000, 11:4359-4368.
13. Ehrenfeld P., Matus C.E., Pavicic F., Toledo C., Nualart F., Gonzalez C.B., et al. Kinin B1 receptor activation turns on exocytosis of matrix metalloprotease-9 and myeloperoxidase in human neutrophils: involvement of mitogen-activated protein kinase family. J Leukoc Biol 2009, 86:1179-1189.
14. Erickson R.W., Langel-Peveri P., Traynor-Kaplan A.E., Heyworth P.G., Curnutte J.T. Activation of human neutrophil NADPH oxidase by phosphatidic acid or diacylglycerol in a cell-free system. Activity of diacylglycerol is dependent on its conversion to phosphatidic acid. J Biol Chem 1999, 274:22243-22250.
15. Gillooly D.J., Melendez A.J., Hockaday A.R., Harnett M.M., Allen J.M. Endocytosis and vesicular trafficking of immune complexes and activation of phospholipase D by the human high-affinity IgG receptor requires distinct phosphoinositide 3-kinase activities. Biochem J 1999, 344(Pt 2):605-611.
16. Hammond S.M., Altshuller Y.M., Sung T.C., Rudge S.A., Rose K., Engebrecht J., et al. Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J Biol Chem 1995, 270:29640-29643.
17. Hammond S.M., Jenco J.M., Nakashima S., Cadwallader K., Gu Q., Cook S., et al. Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and rho family monomeric GTP-binding proteins and protein kinase C-alpha. J Biol Chem 1997, 272:3860-3868.
18. Honda A., Nogami M., Yokozeki T., Yamazaki M., Nakamura H., Watanabe H., et al. Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell 1999, 99:521-532.
19. Humeau Y., Vitale N., Chasserot-Golaz S., Dupont J.L., Du G., Frohman M.A., et al. A role for phospholipase D1 in neurotransmitter release. Proc Natl Acad Sci USA 2001, 98:15300-15305.
20. Hurst N.P., French J.K., Bell A.L., Nuki G., O'Donnell M.L., Betts W.H., et al. Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes. Biochem Pharmacol 1986, 35:3083-3089.
21. Jang J.H., Lee C.S., Hwang D., Ryu S.H. Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners. Prog Lipid Res 2012, 51:71-81.
22. Jiang H., Kuang Y., Wu Y., Xie W., Simon M.I., Wu D. Roles of phospholipase C beta2 in chemoattractant-elicited responses. Proc Natl Acad Sci USA 1997, 94:7971-7975.
23. Kaibuchi K., Takai Y., Nishizuka Y. Cooperative roles of various membrane phospholipids in the activation of calcium-activated, phospholipid-dependent protein kinase. J Biol Chem 1981, 256:7146-7149.
24. Kaldi K., Szeberenyi J., Rada B.K., Kovacs P., Geiszt M., Mocsai A., et al. Contribution of phopholipase D and a brefeldin A-sensitive ARF to chemoattractant-induced superoxide production and secretion of human neutrophils. J Leukoc Biol 2002, 71:695-700.
25. Kanaho Y., Funakoshi Y., Hasegawa H. Phospholipase D signalling and its involvement in neurite outgrowth. Biochim Biophys Acta 2009, 1791:898-904.
26. Kanaho Y., Kanoh H., Saitoh K., Nozawa Y. Phospholipase D activation by platelet-activating factor, leukotriene B4, and formyl-methionyl-leucyl-phenylalanine in rabbit neutrophils. Phospholipase D activation is involved in enzyme release. J Immunol 1991, 46:3536-3541.
27. Kessels G.C., Krause K.H., Verhoeven A.J. Protein kinase C activity is not involved in N-formylmethionyl-leucyl-phenylalanine-induced phospholipase D activation in human neutrophils, but is essential for concomitant NADPH oxidase activation: studies with a staurosporine analogue with improved selectivity for protein kinase C. Biochem J 1993, 292(Pt 3):781-785.
28. Kobayashi E., Nakano H., Morimoto M., Tamaoki T., Calphostin C. (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989, 159:548-553.
29. Koch T., Brandenburg L.O., Schulz S., Liang Y., Klein J., Hollt V. ADP-ribosylation factor-dependent phospholipase D2 activation is required for agonist-induced mu-opioid receptor endocytosis. J Biol Chem 2003, 278:9979-9985.
30. Korchak H.M., Dorsey L.B., Li H., Mackie D., Kilpatrick L.E. Selective roles for alpha-PKC in positive signaling for O-(2) generation and calcium mobilization but not elastase release in differentiated HL60 cells. Biochim Biophys Acta 2007, 1773:440-449.
31. Kuan Y.H., Lin R.H., Tsao L.T., Lin C.N., Wang J.P. Artocarpol A stimulation of superoxide anion generation in neutrophils involved the activation of PLC, PKC and p38 mitogen-activated PK signaling pathways. Br J Pharmacol 2005, 145:460-468.
32. Liscovitch M., Czarny M., Fiucci G., Tang X. Phospholipase D: molecular and cell biology of a novel gene family. Biochem J 2000, 345(Pt 3):401-415.
33. Melendez A., Floto R.A., Gillooly D.J., Harnett M.M., Allen J.M. FcgammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. J Biol Chem 1998, 273:9393-9402.
34. 2+ channel; from discovery to new signaling concepts. J Neurochem 2007, 102:1426-1446.
35. Monovich L., Mugrage B., Quadros E., Toscano K., Tommasi R., LaVoie S., et al. Optimization of halopemide for phospholipase D2 inhibition. Bioorg Med Chem Lett 2007, 17:2310-2311.
36. Morris A.J., Frohman M.A., Engebrecht J. Measurement of phospholipase D activity. Anal Biochem 1997, 252:1-9.
37. Nanamori M., Chen J., Du X., Ye R.D. Regulation of leukocyte degranulation by cGMP-dependent protein kinase and phosphoinositide 3-kinase: potential roles in phosphorylation of target membrane SNARE complex proteins in rat mast cells. J Immunol 2007, 178:416-427.
38. Nick J.A., Avdi N.J., Young S.K., Knall C., Gerwins P., Johnson G.L., et al. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J Clin Invest 1997, 99:975-986.
39. Nishioka H., Horiuchi H., Arai H., Kita T. Lysophosphatidylcholine generates superoxide anions through activation of phosphatidylinositol 3-kinase in human neutrophils. FEBS Lett 1998, 441:63-66.
40. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984, 308:693-698.
41. Nordenfelt P., Tapper H. Phagosome dynamics during phagocytosis by neutrophils. J Leukoc Biol 2011, 90:271-284.
42. Oh K.J., Lee S.C., Choi H.J., Oh D.Y., Kim S.C., Min do S., et al. Role of phospholipase D2 in anti-apoptotic signaling through increased expressions of Bcl-2 and Bcl-xL. J Cell Biochem 2007, 101:1409-1422.
43. Padron D., Tall R.D., Roth M.G. Phospholipase D2 is required for efficient endocytic recycling of transferrin receptors. Mol Biol Cell 2006, 17:598-606.
44. Pai J.K., Siegel M.I., Egan R.W., Billah M.M. Phospholipase D catalyzes phospholipid metabolism in chemotactic peptide-stimulated HL-60 granulocytes. J Biol Chem 1988, 263:12472-12477.
45. Phillipson M., Kubes P. The neutrophil in vascular inflammation. Nat Med 2011, 17:1381-1390.
46. Rudge S.A., Wakelam M.J. Inter-regulatory dynamics of phospholipase D and the actin cytoskeleton. Biochim Biophys Acta 2009, 1791:856-861.
47. Sadik C.D., Kim N.D., Luster A.D. Neutrophils cascading their way to inflammation. Trends Immunol 2011, 32:452-460.
48. Selvatici R., Falzarano S., Mollica A., Spisani S. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur J Pharmacol 2006, 34:1-11.
49. Simard J.C., Girard D., Tessier P.A. Induction of neutrophil degranulation by S100A9 via a MAPK-dependent mechanism. J Leukoc Biol 2010, 87:905-914.
50. Smith J.A. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994, 56:672-686.
51. Smith R.J., Sam L.M., Justen J.M., Bundy G.L., Bala G.A., Bleasdale J.E. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J Pharmacol Exp Ther 1990, 253:688-697.
52. Stace C.L., Ktistakis N.T. Phosphatidic acid- and phosphatidylserine-binding proteins. Biochim Biophys Acta 2006, 1761:913-926.
53. Steinberg S.F. Structural basis of protein kinase C isoform function. Physiol Rev 2008, 88:1341-1378.
54. Su W., Yeku O., Olepu S., Genna A., Park J.S., Ren H., et al. 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol Pharmacol 2009, 75:437-446.
55. Suh P.G., Park J.I., Manzoli L., Cocco L., Peak J.C., Katan M., et al. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 2008, 41:415-434.
56. Watanabe H., Yamazaki M., Miyazaki H., Arikawa C., Itoh K., Sasaki T., et al. Phospholipase D2 functions as a downstream signaling molecule of MAP kinase pathway in L1-stimulated neurite outgrowth of cerebellar granule neurons. J Neurochem 2004, 89:142-151.
57. Yamamori T., Inanami O., Nagahata H., Kuwabara M. Phosphoinositide 3-kinase regulates the phosphorylation of NADPH oxidase component p47(phox) by controlling cPKC/PKCdelta but not Akt. Biochem Biophys Res Commun 2004, 316:720-730.
58. Yang S.F., Freer S., Benson A.A. Transphosphatidylation by phospholipase D. J Biol Chem 1967, 242:477-484.